Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 14/20 | 0.67 |
| ▸ | ADRA2B | P18089 | 14/20 | 0.67 |
| ▸ | ADRA2C | P18825 | 14/20 | 0.67 |
| ▸ | MAOA | P21397 | 9/20 | 0.67 |
| ▸ | MAOB | P27338 | 9/20 | 0.67 |
| ▸ | NISCH | Q9Y2I1 | 7/20 | 0.67 |
| ▸ | HTR1A | P08908 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17887853 | 0.80 | ADRA2A (1.00) | ADRA2AADRA2BADRA2CMAOAMAOB | |
| SCHEMBL11246125 | 0.76 | ADRA2B (0.61) | ADRA2AADRA2BADRA2CMAOAMAOB | |
| SCHEMBL3717495 | 0.73 | ADRA2B (0.57) | ADRA2AADRA2BADRA2CMAOAMAOB | |
| SCHEMBL17887783 | 0.71 | ADRA2A (0.58) | ADRA2AADRA2BADRA2CMAOAMAOB | |
| SCHEMBL954313 | 0.69 | ADRA2A (0.62) | ADRA2AADRA2BADRA2CMAOAMAOB | |
| Hydrochloric Acid SCHEMBL953199 | 0.68 | ADRA2A (0.64) | ADRA2AADRA2BADRA2CMAOAMAOB | |
| SCHEMBL11830821 | 0.67 | ADRA2A (0.57) | ADRA2AADRA2BADRA2CMAOAMAOB | |
| SCHEMBL952920 | 0.67 | ADRA2A (0.65) | ADRA2AADRA2BADRA2CMAOAMAOB | |
| SCHEMBL4372423 | 0.67 | ADRA2A (0.57) | ADRA2AADRA2BADRA2CMAOAMAOB | |
| SCHEMBL17887849 | 0.66 | MAOA (0.76) | ADRA2AADRA2BADRA2CMAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100120882-A1 | PHENOXYMETHYL IMIDAZOLINE DERIVATIVES AND THEIR USE AS PESTICIDES | SYNGENTA CROP PROTECTION, INC. (US) | 2010-05-13 | — | — | US | disclosed |
| EP-2120574-A2 | PHENOXYMETHYL IMIDAZOLINE DERIVATIVES AND THEIR USE AS PESTICIDES | Sygenta Participations AG. (CH) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008098674-A2 | PHENOXYMETHYL IMIDAZOLINE DERIVATIVES AND THEIR USE AS PESTICIDES | SYGENTA PARTICIPATIONS AG (CH) | 2008-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100120882-A1 | PHENOXYMETHYL IMIDAZOLINE DERIVATIVES AND THEIR USE AS PESTICIDES | ACHE, DDT, API5 | ADRA2A 1752/4885ADRA2B 2099/4885ADRA2C 499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.